MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 4 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $95,000 | +15.9% | 76,217 | +187.9% | 0.00% | 0.0% |
| Q1 2017 | $82,000 | -68.2% | 26,473 | -58.1% | 0.00% | -50.0% |
| Q4 2016 | $258,000 | +103.1% | 63,191 | +216.9% | 0.00% | +100.0% |
| Q3 2016 | $127,000 | 0.0% | 19,938 | +94.6% | 0.00% | 0.0% |
| Q2 2015 | $127,000 | -37.1% | 10,248 | -39.9% | 0.00% | 0.0% |
| Q1 2015 | $202,000 | +25.5% | 17,040 | +19.7% | 0.00% | 0.0% |
| Q4 2014 | $161,000 | +140.3% | 14,241 | +6.9% | 0.00% | – |
| Q1 2014 | $67,000 | -4.3% | 13,326 | -27.3% | 0.00% | – |
| Q3 2013 | $70,000 | – | 18,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,442,159 | $15,508,000 | 3.96% |
| Consonance Capital Management LP | 5,950,225 | $37,784,000 | 3.64% |
| Lagoda Investment Management, L.P. | 1,870,777 | $11,879,000 | 3.57% |
| ALTFEST L J & CO INC | 39,490 | $1,508,000 | 1.00% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $525,000 | 0.49% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8,894,008 | $56,477,000 | 0.46% |
| Cannell & Co. | 1,611,678 | $10,234,000 | 0.37% |
| Portolan Capital Management | 412,189 | $2,617,000 | 0.36% |
| Virtus ETF Advisers LLC | 100,090 | $636,000 | 0.31% |
| INDUS CAPITAL PARTNERS, LLC | 500,000 | $3,175,000 | 0.30% |